PS1071 PRELIMINARY RESULTS OF A PHASE 1 DOSE ESCALATION STUDY OF THE FIRST-IN-CLASS ANTI-CD74 ANTIBODY DRUG CONJUGATE (ADC), STRO-001, IN PATIENTS WITH ADVANCED B-CELL MALIGNANCIES

Authors :: N. Shah
A. Krishnan
J. Burke
J. Melear
A. Spira
L. Popplewell
C. Andreadis
S. Chhabra
J. Sharman
J. Kaufman
J. Cohen
R. Niesvizky
T. Martin
C. DiLea
J. Kuriakose
S. Matheny
A. Molina
Source :: HemaSphere. 3:485
Publication Year :: 2019
Publisher :: Ovid Technologies (Wolters Kluwer Health), 2019.

Subjects :: Antibody-drug conjugate
medicine.anatomical_structure
CD74
business.industry
Dose escalation
medicine
Cancer research
In patient
Hematology
business
B cell

Full Text Access

Tools